A PHASE 2, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PARALLEL-GROUP STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF INDUCTION THERAPY WITH RPC1063 IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Category Primary study
Registry of TrialsOverview of Medical Research in the Netherlands
Year 2013
This article has no abstract
Epistemonikos ID: e006d451beea309e244cbd4a92ba64877de4238c
First added on: Apr 16, 2025